Centro Di Riferimento Oncologico Di Aviano
- Address
- lock Available on a paid plan
Neoplasms
The site conducts extensive research on solid tumors, targeting a broad spectrum of cancers.
- Advanced breast cancer
- Metastatic colorectal cancer
- HER2‑positive gastric cancer
- High‑grade serous ovarian cancer
- Metastatic renal cell carcinoma
Trials aim to evaluate novel targeted therapies and immunotherapy regimens to improve survival.
Hemic and Lymphatic Diseases
Investigations focus on hematologic malignancies including leukemia and lymphoma.
- Chronic lymphocytic leukemia
- Diffuse large B‑cell lymphoma
- Multiple myeloma
- Follicular lymphoma
- Acute myeloid leukemia
Studies assess the efficacy of new cell‑based immunotherapies and combination regimens.
Respiratory Tract Diseases
Research addresses lung cancers and related thoracic conditions.
- Non‑small cell lung cancer
- Small‑cell lung cancer
- Large‑cell neuroendocrine carcinoma
- Malignant pleural mesothelioma
- KRAS‑mutated NSCLC
Goals include testing innovative immuno‑oncology agents and precision‑medicine approaches.
Digestive System Diseases
Clinical work explores gastro‑intestinal malignancies across the digestive tract.
- Colorectal cancer
- Gastric adenocarcinoma
- Pancreatic ductal adenocarcinoma
- Small bowel adenocarcinoma
- Hepatocellular carcinoma
Efforts seek to improve treatment sequencing and biomarker‑driven therapies.
Female Urogenital Diseases
Studies concentrate on gynecologic cancers affecting women.
- Ovarian carcinoma
- Endometrial carcinoma
- Cervical cancer
- Fallopian tube cancer
- High‑risk HR‑positive/HER2‑negative breast cancer
Trials evaluate new hormone‑targeted and immunotherapeutic options.
Musculoskeletal Diseases
The department investigates bone and soft‑tissue sarcomas.
- Leiomyosarcoma
- Osteosarcoma
- Soft‑tissue sarcoma
- Metastatic bone disease
- Sarcoma with novel agents
Research aims to determine the benefit of targeted kinase inhibitors in sarcoma care.
Nutritional and Metabolic Diseases
Projects include metabolic profiling in cancer patients, focusing on nutritional status.
- Cancer‑associated cachexia
- Metabolic biomarkers
- Nutritional support interventions
- Obesity‑related cancer risk
- Diabetes impact on treatment
Objectives are to refine supportive care strategies that enhance outcomes.
Skin and Connective Tissue Diseases
Research covers melanoma and cutaneous tumors.
- Melanoma
- Merkel cell carcinoma
- Cutaneous squamous cell carcinoma
- Dermatologic manifestations of systemic therapy
- Immunotherapy for skin cancers
Studies aim to validate immune checkpoint inhibitors and combination approaches.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 16 therapeutic areas and 15 of 282 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 272 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 71 by active trials.
lock +70 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Fondazione Italiana Linfomi Ets11trials
lock +36 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro Di Riferimento Oncologico Di Aviano
lock Showing 1 of 213 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors | Cogent Biosciences Inc. | Phase III | Not Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 282 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 43 | Unknown | 2018-07-31 | 2026-06-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.